Table 6. Percentages of resistance of all clinical isolated bacteria to three antibiotics of the cephalosporin group (%).
Bacteria | Cefepime 30 µg/disc |
Ceftazidime 30 µg/disc |
Cefuroxime 30 µg/disc |
||||||
1st phase | 2nd phase | 3rd phase | 1st phase | 2nd phase | 3rd phase | 1st phase | 2nd phase | 3rd phase | |
E. faecalis | 65 | 70 | 76 | 62 | 68 | 69 | 51 | 54 | 58 |
S. aureus | 61 | 67 | 78 | 78 | 84 | 86 | 62 | 66 | 68 |
A. baumannii | 38 | 42 | 49 | 32 | 41 | 48 | 50 | 56 | 62 |
Citrobacter sp. | 29 | 35 | 40 | 22 | 27 | 34 | 37 | 38 | 38 |
E. aerogenes | 32 | 41 | 52 | 35 | 39 | 45 | 72 | 77 | 79 |
E. coli | 58 | 62 | 69 | 67 | 71 | 78 | 75 | 80 | 82 |
K. pneumoniae | 54 | 67 | 71 | 64 | 69 | 73 | 71 | 72 | 75 |
K. oxytoca | 35 | 41 | 47 | 21 | 29 | 32 | 32 | 39 | 42 |
P. mirabilis | 27 | 31 | 35 | 37 | 34 | 35 | 27 | 31 | 34 |
P. vulgaris | 34 | 39 | 42 | 34 | 43 | 45 | 38 | 46 | 47 |
P. aeruginosa | 75 | 79 | 81 | 75 | 77 | 83 | 67 | 76 | 82 |
1st phase: April-September 2011; 2nd phase: October 2011-March 2012; 3rd phase: April-September 2012.